AbbVie abandons late-stage lung cancer asset Rova-T - WTVB News
AbbVie abandons late-stage lung cancer asset Rova-T WTVB News
(Reuters) - AbbVie Inc said on Thursday it will cease to develop its experimental drug Rova-T after the treatment failed to show survival benefit in a late-stage ...
Comments
Post a Comment